EA199900963A1 - Лекарственные формы сертралина в виде раствора, заключенного в желатиновые капсулы - Google Patents

Лекарственные формы сертралина в виде раствора, заключенного в желатиновые капсулы

Info

Publication number
EA199900963A1
EA199900963A1 EA199900963A EA199900963A EA199900963A1 EA 199900963 A1 EA199900963 A1 EA 199900963A1 EA 199900963 A EA199900963 A EA 199900963A EA 199900963 A EA199900963 A EA 199900963A EA 199900963 A1 EA199900963 A1 EA 199900963A1
Authority
EA
Eurasian Patent Office
Prior art keywords
capsules
gelatinic
sertralin
concluded
solution
Prior art date
Application number
EA199900963A
Other languages
English (en)
Other versions
EA001905B1 (ru
Inventor
Уильям Джон Кьюратоло
Рави Майсор Шенкер
Original Assignee
Пфайзер Продактс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971076&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA199900963(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Пфайзер Продактс Инк. filed Critical Пфайзер Продактс Инк.
Publication of EA199900963A1 publication Critical patent/EA199900963A1/ru
Publication of EA001905B1 publication Critical patent/EA001905B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Лекарственные формы сертралина, заключенного в капсулы в не смешивающемся с водой наполнителе, сокращающие Ти/или уменьшающие побочные действия и/или уменьшающие выпадение сертралина в осадок в хлорид-ионсодержащих применяемых средах, таких как желудочно-кишечный тракт.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199900963A 1997-07-01 1998-06-16 Лекарственная форма сертралина в виде раствора, заключенного в желатиновые капсулы EA001905B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5140197P 1997-07-01 1997-07-01
PCT/IB1998/000936 WO1999001113A1 (en) 1997-07-01 1998-06-16 Gelatine encapsulated solution dosage forms of sertraline

Publications (2)

Publication Number Publication Date
EA199900963A1 true EA199900963A1 (ru) 2000-08-28
EA001905B1 EA001905B1 (ru) 2001-10-22

Family

ID=21971076

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900963A EA001905B1 (ru) 1997-07-01 1998-06-16 Лекарственная форма сертралина в виде раствора, заключенного в желатиновые капсулы

Country Status (40)

Country Link
EP (1) EP0980241B1 (ru)
JP (1) JP3585245B2 (ru)
KR (1) KR100371730B1 (ru)
CN (1) CN1261792A (ru)
AP (1) AP945A (ru)
AR (1) AR015916A1 (ru)
AT (1) ATE256457T1 (ru)
AU (1) AU724635B2 (ru)
BG (1) BG103917A (ru)
BR (1) BR9809712A (ru)
CA (1) CA2290973C (ru)
CO (1) CO4940405A1 (ru)
DE (1) DE69820608T2 (ru)
DK (1) DK0980241T3 (ru)
DZ (1) DZ2544A1 (ru)
EA (1) EA001905B1 (ru)
ES (1) ES2210760T3 (ru)
GT (1) GT199800090A (ru)
HR (1) HRP980378B1 (ru)
HU (1) HUP0002250A3 (ru)
ID (1) ID24673A (ru)
IL (1) IL133075A0 (ru)
IS (1) IS5266A (ru)
MA (1) MA24586A1 (ru)
MY (1) MY119728A (ru)
NO (1) NO996492L (ru)
NZ (1) NZ501252A (ru)
OA (1) OA11246A (ru)
PA (1) PA8454001A1 (ru)
PE (1) PE97299A1 (ru)
PL (1) PL337807A1 (ru)
PT (1) PT980241E (ru)
SK (1) SK282914B6 (ru)
TN (1) TNSN98123A1 (ru)
TR (1) TR199903282T2 (ru)
TW (1) TW382597B (ru)
UA (1) UA68350C2 (ru)
UY (1) UY25070A1 (ru)
WO (1) WO1999001113A1 (ru)
ZA (1) ZA985709B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9914418A (pt) * 1998-10-13 2001-06-26 Pfizer Prod Inc Concentrado oral de sertralina
US6727283B2 (en) 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
ATE318135T1 (de) 1999-09-03 2006-03-15 Apbi Holdings Llc Verwendung von dapoxetin, a selektiver serotonin- aufnahme inhibitor mit schnellem wirkungseintritt,zur behandlung von sexueller dysfunction
JP2004507502A (ja) 2000-08-30 2004-03-11 ファイザー・プロダクツ・インク 成長ホルモン分泌促進物質のための徐放性製剤
EP1375659A1 (en) * 2002-06-18 2004-01-02 Laboratorio di Diagnostica Moleculare Soluble capsules containing stock mixtures for easy preparation of chemical or biological solutions
JP2006507309A (ja) * 2002-10-31 2006-03-02 アルザ・コーポレーシヨン 疎水性薬剤の上昇した生物学的利用性を提供する製剤
WO2016020936A2 (en) * 2014-07-21 2016-02-11 Patel Jayendrakumar Dasharathlal A novel oral gastroretentive pharmaceutical dosage form
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996009047A1 (en) * 1994-09-19 1996-03-28 The Du Pont Merck Pharmaceutical Company Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence
PT768083E (pt) * 1995-07-17 2003-08-29 Pfizer Sertralina para o tratamento de doentes pos-enfarte miocardico

Also Published As

Publication number Publication date
IL133075A0 (en) 2001-03-19
SK180599A3 (en) 2001-01-18
WO1999001113A1 (en) 1999-01-14
TNSN98123A1 (fr) 2005-03-15
PT980241E (pt) 2004-03-31
ID24673A (id) 2000-07-27
TR199903282T2 (xx) 2000-08-21
SK282914B6 (sk) 2003-01-09
DZ2544A1 (fr) 2003-02-08
AP9801279A0 (en) 1998-06-30
CA2290973A1 (en) 1999-01-14
UY25070A1 (es) 2000-12-29
AP945A (en) 2001-02-28
IS5266A (is) 1999-11-23
ATE256457T1 (de) 2004-01-15
HUP0002250A3 (en) 2001-01-29
AR015916A1 (es) 2001-05-30
KR100371730B1 (ko) 2003-02-07
BG103917A (bg) 2000-07-31
CO4940405A1 (es) 2000-07-24
PE97299A1 (es) 1999-10-13
NZ501252A (en) 2004-11-26
ZA985709B (en) 2000-01-10
ES2210760T3 (es) 2004-07-01
JP3585245B2 (ja) 2004-11-04
JP2000512316A (ja) 2000-09-19
BR9809712A (pt) 2000-07-11
UA68350C2 (en) 2004-08-16
EP0980241B1 (en) 2003-12-17
PL337807A1 (en) 2000-09-11
HRP980378A2 (en) 1999-04-30
MA24586A1 (fr) 1998-12-31
AU724635B2 (en) 2000-09-28
NO996492L (no) 2000-02-29
CN1261792A (zh) 2000-08-02
TW382597B (en) 2000-02-21
DE69820608D1 (de) 2004-01-29
HRP980378B1 (en) 2001-12-31
PA8454001A1 (es) 2000-05-24
GT199800090A (es) 1999-12-21
DE69820608T2 (de) 2004-12-23
OA11246A (en) 2002-11-19
EP0980241A1 (en) 2000-02-23
AU7545098A (en) 1999-01-25
CA2290973C (en) 2003-06-17
NO996492D0 (no) 1999-12-27
EA001905B1 (ru) 2001-10-22
DK0980241T3 (da) 2004-04-05
HUP0002250A2 (hu) 2000-12-28
KR20010013588A (ko) 2001-02-26
MY119728A (en) 2005-07-29

Similar Documents

Publication Publication Date Title
ATE265857T1 (de) Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie
CY2007001I1 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
DE68905374T2 (de) Mittel zur vorbeugung und abhilfe gegen ischaemische verletzungen.
ATE232100T1 (de) Gegen magensaft geschützte omeprazol- mikrogranülen, herstellungsverfahren und pharmazeutische zubereitungen
PT1212317E (pt) Derivados de indole e sua utilizacao no tratamento de osteoporose entre outras aplicacoes
DE69931799D1 (de) Absorptionsbeschleuniger und diese enthaltende zubereitungen zur transdermalen absorption
ZA9811445B (en) Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions.
NO20011409D0 (no) Farmasøytiske midler for behandling av Parkinsonssykdom, ADHD og mikroadenomer
DE69324826D1 (de) Gegen Papillomaviren wirksame 2',5'-OLIGOADENYLAT-2',3'-CYCLOPHOSPHATE und 2',5'-OLIGOADENYLATE
GB2375340B (en) Gelatin substitute
IS1966B (is) Peptíð p277 hliðstæður og lyfjasamsetningar sem innihalda þær, til meðhöndlunar eða sjúkdómsgreiningar á sykursýki
EP0347864A3 (en) Anti-atherogenic agents
EA199900963A1 (ru) Лекарственные формы сертралина в виде раствора, заключенного в желатиновые капсулы
ITRM930291A0 (it) Procedimento per la preparazione di biopolimeri iodurati con attivita'disinfettante e cicatrizzante, e biopolimeri iodurati cosi' ottenuti.
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
HRP20040171A2 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
DE69939075D1 (de) Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten
PT1152762E (pt) Utilizacao de desoxipeganina no tratamento da demencia de alzheimer
ZA992406B (en) Use of sulodexide and of the medicines containing it in the treatment of the diabetic retinopathy.
DE69912315D1 (de) ((aminoiminomethyl)amino) alkanecarboxamide und deren therapeutische verwendungen
RU99116456A (ru) Лекарственное средство для профилактики и лечения вирусных болезней животных
DE69513632D1 (de) Mikrogranulate enthaltend 5-nitroimidazolderivate
RU93035343A (ru) Вещество, обладающее антиагрегантной активностью
ID28817A (id) Penggunaan turunan-turunan tetrahidropiridin (atau4-hidropiperidin)-butilazol dalam pembuatan obat untuk perawatan nyeri

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU